Published in J Virol on January 13, 2010
Neutralizing epitopes of influenza virus hemagglutinin: target for the development of a universal vaccine against H5N1 lineages. J Virol (2010) 1.16
A recombinant vaccine of H5N1 HA1 fused with foldon and human IgG Fc induced complete cross-clade protection against divergent H5N1 viruses. PLoS One (2011) 1.08
Display of VP1 on the surface of baculovirus and its immunogenicity against heterologous human enterovirus 71 strains in mice. PLoS One (2011) 0.93
Intranasal immunization of baculovirus displayed hemagglutinin confers complete protection against mouse adapted highly pathogenic H7N7 reassortant influenza virus. PLoS One (2013) 0.81
Adaptive immune responses elicited by baculovirus and impacts on subsequent transgene expression in vivo. J Virol (2013) 0.81
Mucosal delivery of ACNPV baculovirus driving expression of the Gal-lectin LC3 fragment confers protection against amoebic liver abscess in hamster. Int J Biol Sci (2011) 0.80
Hemagglutinin-based polyanhydride nanovaccines against H5N1 influenza elicit protective virus neutralizing titers and cell-mediated immunity. Int J Nanomedicine (2014) 0.79
Viral vector-based influenza vaccines. Hum Vaccin Immunother (2016) 0.79
Immunobiology of influenza vaccines. Chest (2013) 0.78
Subcutaneous immunization with baculovirus surface-displayed hemagglutinin of pandemic H1N1 Influenza A virus induces protective immunity in mice. Clin Vaccine Immunol (2011) 0.77
Recombinant baculovirus associated with bilosomes as an oral vaccine candidate against HEV71 infection in mice. PLoS One (2013) 0.76
Protection against Amoebic Liver Abscess in Hamster by Intramuscular Immunization with an Autographa californica Baculovirus Driving the Expression of the Gal-Lectin LC3 Fragment. Biomed Res Int (2015) 0.75
Construction of recombinant baculoviruses expressing hemagglutinin of H5N1 avian influenza and research on the immunogenicity. Sci Rep (2016) 0.75
Recombinant baculovirus displayed vaccine: a novel tool for the development of a cross-protective influenza H5N1 vaccine. Bioengineered (2013) 0.75
Adamantane resistance among influenza A viruses isolated early during the 2005-2006 influenza season in the United States. JAMA (2006) 8.06
Evolution of H5N1 avian influenza viruses in Asia. Emerg Infect Dis (2005) 6.99
Structure of the uncleaved human H1 hemagglutinin from the extinct 1918 influenza virus. Science (2004) 6.70
Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep (2004) 5.00
Assembly of influenza hemagglutinin trimers and its role in intracellular transport. J Cell Biol (1986) 4.93
Live, attenuated influenza A H5N1 candidate vaccines provide broad cross-protection in mice and ferrets. PLoS Med (2006) 3.71
Safety and immunogenicity of a recombinant hemagglutinin vaccine for H5 influenza in humans. Vaccine (2001) 3.09
Virus-like particle vaccine induces protective immunity against homologous and heterologous strains of influenza virus. J Virol (2007) 2.71
Cross-protection in mice infected with influenza A virus by the respiratory route is correlated with local IgA antibody rather than serum antibody or cytotoxic T cell reactivity. Eur J Immunol (1984) 2.57
Cross-clade protective immune responses to influenza viruses with H5N1 HA and NA elicited by an influenza virus-like particle. PLoS One (2008) 2.16
Comparative efficacy of neutralizing antibodies elicited by recombinant hemagglutinin proteins from avian H5N1 influenza virus. J Virol (2008) 2.14
Vaccination strategies for mucosal immune responses. Clin Microbiol Rev (2001) 1.98
Efficacy of nucleoprotein and haemagglutinin antigens expressed in fowlpox virus as vaccine for influenza in chickens. Vaccine (1991) 1.66
Baculovirus induces an innate immune response and confers protection from lethal influenza virus infection in mice. J Immunol (2003) 1.57
Recombinant baculoviruses as mammalian cell gene-delivery vectors. Trends Biotechnol (2002) 1.55
Safety and immunogenicity of a baculovirus-expressed hemagglutinin influenza vaccine: a randomized controlled trial. JAMA (2007) 1.52
In vitro and in vivo gene delivery by recombinant baculoviruses. J Virol (2003) 1.38
Baculovirus stimulates antiviral effects in mammalian cells. J Virol (1999) 1.26
Insect baculoviruses strongly potentiate adaptive immune responses by inducing type I IFN. J Immunol (2007) 1.25
Protective immunity against influenza H5N1 virus challenge in mice by intranasal co-administration of baculovirus surface-displayed HA and recombinant CTB as an adjuvant. Virology (2008) 1.25
Novel approach to the development of effective H5N1 influenza A virus vaccines: use of M2 cytoplasmic tail mutants. J Virol (2007) 1.20
Development of epitope-blocking ELISA for universal detection of antibodies to human H5N1 influenza viruses. PLoS One (2009) 1.12
Effect of different baculovirus inactivation procedures on the integrity and immunogenicity of porcine parvovirus-like particles. Vaccine (2000) 1.03
Baculoviral display of the green fluorescent protein and rubella virus envelope proteins. Biochem Biophys Res Commun (1997) 1.01
Dose-related safety and immunogenicity of baculovirus-expressed trivalent influenza vaccine: a double-blind, controlled trial in adult patients with non-Hodgkin B cell lymphoma. J Infect Dis (2006) 0.97
The potential use of receptor-mediated endocytosis for oral drug delivery. Adv Drug Deliv Rev (2001) 0.94
Baculovirus vector as a delivery vehicle for influenza vaccines. Expert Rev Vaccines (2009) 0.92
Optimisation of a lipid based oral delivery system containing A/Panama influenza haemagglutinin. Vaccine (2004) 0.91
A chimeric baculovirus displaying bovine herpesvirus-1 (BHV-1) glycoprotein D on its surface and their immunological properties. Appl Microbiol Biotechnol (2007) 0.87
Baculovirus is an efficient vector for the transduction of the eye: comparison of baculovirus- and adenovirus-mediated intravitreal vascular endothelial growth factor D gene transfer in the rabbit eye. J Gene Med (2009) 0.82
Antibody response in the intestinal tract of mice orally immunized with antigen associated with liposomes. J Vet Med Sci (1998) 0.81
Immune response in the lungs following oral immunization with bacterial lysates of respiratory pathogens. Clin Diagn Lab Immunol (1994) 0.79
Characterization of a previously unidentified viral protein in porcine circovirus type 2-infected cells and its role in virus-induced apoptosis. J Virol (2005) 1.92
Monoclonal antibodies against the fusion peptide of hemagglutinin protect mice from lethal influenza A virus H5N1 infection. J Virol (2008) 1.62
Betanodavirus B2 is an RNA interference antagonist that facilitates intracellular viral RNA accumulation. J Virol (2006) 1.30
The ORF3 protein of porcine circovirus type 2 is involved in viral pathogenesis in vivo. J Virol (2006) 1.26
Protective immunity against influenza H5N1 virus challenge in mice by intranasal co-administration of baculovirus surface-displayed HA and recombinant CTB as an adjuvant. Virology (2008) 1.25
Lung CD103+ dendritic cells efficiently transport influenza virus to the lymph node and load viral antigen onto MHC class I for presentation to CD8 T cells. J Immunol (2011) 1.21
Neutralizing epitopes of influenza virus hemagglutinin: target for the development of a universal vaccine against H5N1 lineages. J Virol (2010) 1.16
Immunological characterization of the spike protein of the severe acute respiratory syndrome coronavirus. J Clin Microbiol (2004) 1.13
Development of epitope-blocking ELISA for universal detection of antibodies to human H5N1 influenza viruses. PLoS One (2009) 1.12
GM-CSF and IL-4 stimulate antibody responses in humanized mice by promoting T, B, and dendritic cell maturation. J Immunol (2012) 1.11
Combination therapy using chimeric monoclonal antibodies protects mice from lethal H5N1 infection and prevents formation of escape mutants. PLoS One (2009) 1.10
Detection of H5 avian influenza viruses by antigen-capture enzyme-linked immunosorbent assay using H5-specific monoclonal antibody. Clin Vaccine Immunol (2007) 1.09
Influenza A virus infection results in a robust, antigen-responsive, and widely disseminated Foxp3+ regulatory T cell response. J Virol (2011) 1.09
RING-H2 protein WSSV249 from white spot syndrome virus sequesters a shrimp ubiquitin-conjugating enzyme, PvUbc, for viral pathogenesis. J Virol (2005) 1.09
Identification of white spot syndrome virus latency-related genes in specific-pathogen-free shrimps by use of a microarray. J Virol (2003) 1.08
Baculovirus as vaccine vectors. Curr Gene Ther (2010) 1.03
Characterization of an isotype-dependent monoclonal antibody against linear neutralizing epitope effective for prophylaxis of enterovirus 71 infection. PLoS One (2012) 1.02
White spot syndrome virus open reading frame 222 encodes a viral E3 ligase and mediates degradation of a host tumor suppressor via ubiquitination. J Virol (2006) 1.01
Expression of hemagglutinin protein from the avian influenza virus H5N1 in a baculovirus/insect cell system significantly enhanced by suspension culture. BMC Microbiol (2006) 1.01
Identification and characterization of a new E3 ubiquitin ligase in white spot syndrome virus involved in virus latency. Virol J (2008) 0.99
Development of an antigen-capture ELISA for detection of H7 subtype avian influenza from experimentally infected chickens. J Virol Methods (2007) 0.97
The ORF3 protein of porcine circovirus type 2 interacts with porcine ubiquitin E3 ligase Pirh2 and facilitates p53 expression in viral infection. J Virol (2007) 0.97
Characterization of ORF89--a latency-related gene of white spot syndrome virus. Virology (2004) 0.96
Development of a Western blot assay for detection of antibodies against coronavirus causing severe acute respiratory syndrome. Clin Diagn Lab Immunol (2004) 0.96
Rapid detection of H5N1 subtype influenza viruses by antigen capture enzyme-linked immunosorbent assay using H5- and N1-specific monoclonal antibodies. Clin Vaccine Immunol (2009) 0.96
Retracted Baculovirus surface-displayed hemagglutinin of H5N1 influenza virus sustains its authentic cleavage, hemagglutination activity, and antigenicity. Biochem Biophys Res Commun (2007) 0.95
Characterization of monoclonal antibody against SARS coronavirus nucleocapsid antigen and development of an antigen capture ELISA. J Virol Methods (2005) 0.95
Neuroendocrine-immune interactions in fish: a role for interleukin-1. Vet Immunol Immunopathol (2002) 0.94
Identification of a novel shrimp protein phosphatase and its association with latency-related ORF427 of white spot syndrome virus. FEBS Lett (2004) 0.93
Immunohistochemical detection of Influenza virus infection in formalin-fixed tissues with anti-H5 monoclonal antibody recognizing FFWTILKP. J Virol Methods (2008) 0.93
Display of VP1 on the surface of baculovirus and its immunogenicity against heterologous human enterovirus 71 strains in mice. PLoS One (2011) 0.93
Attenuation of human enterovirus 71 high-replication-fidelity variants in AG129 mice. J Virol (2014) 0.93
WSSV ie1 promoter is more efficient than CMV promoter to express H5 hemagglutinin from influenza virus in baculovirus as a chicken vaccine. BMC Microbiol (2008) 0.92
Baculovirus vector as a delivery vehicle for influenza vaccines. Expert Rev Vaccines (2009) 0.92
Cross-protective efficacy of bivalent recombinant baculoviral vaccine against heterologous influenza H5N1 challenge. Vaccine (2013) 0.92
Membrane association of greasy grouper nervous necrosis virus protein A and characterization of its mitochondrial localization targeting signal. J Virol (2004) 0.91
Prophylactic and therapeutic efficacy of a chimeric monoclonal antibody specific for H5 haemagglutinin against lethal H5N1 influenza. Antivir Ther (2009) 0.91
Characterization and specificity of the linear epitope of the enterovirus 71 VP2 protein. Virol J (2012) 0.91
Dissection of double-stranded RNA binding protein B2 from betanodavirus. J Virol (2007) 0.90
Identification of nucleolus localization signal of betanodavirus GGNNV protein alpha. Virology (2003) 0.90
Sequestration and protection of double-stranded RNA by the betanodavirus b2 protein. J Virol (2006) 0.90
Localization of VP28 on the baculovirus envelope and its immunogenicity against white spot syndrome virus in Penaeus monodon. Virology (2009) 0.89
Baculovirus-mediated promoter assay and transcriptional analysis of white spot syndrome virus orf427 gene. Virol J (2005) 0.88
Induction of caspase-dependent apoptosis by betanodaviruses GGNNV and demonstration of protein alpha as an apoptosis inducer. Virology (2003) 0.88
Attenuation of porcine circovirus 2 in SPF piglets by abrogation of ORF3 function. Virology (2008) 0.86
ORF3 of porcine circovirus 2 enhances the in vitro and in vivo spread of the of the virus. Virology (2010) 0.86
Complementary monoclonal antibody-based dot ELISA for universal detection of H5 avian influenza virus. BMC Microbiol (2010) 0.86
Effective intranasal therapeutics and prophylactics with monoclonal antibody against lethal infection of H7N7 influenza virus. Antiviral Res (2013) 0.86
Evaluation of a safe and sensitive Spike protein-based immunofluorescence assay for the detection of antibody responses to SARS-CoV. J Immunol Methods (2004) 0.85
Vaccination of ducks with recombinant outer membrane protein (OmpA) and a 41 kDa partial protein (P45N') of Riemerella anatipestifer. Vet Microbiol (2002) 0.85
A novel peptide ELISA for universal detection of antibodies to human H5N1 influenza viruses. PLoS One (2011) 0.85
Porcine circovirus type 2 induces the activation of nuclear factor kappa B by IkappaBalpha degradation. Virology (2008) 0.85
Natural compounds inhibiting the replication of Porcine reproductive and respiratory syndrome virus. Antiviral Res (2012) 0.85
Viral ubiquitin ligase WSSV222 is required for efficient white spot syndrome virus replication in shrimp. J Gen Virol (2009) 0.84
Novel immunofluorescence assay using recombinant nucleocapsid-spike fusion protein as antigen to detect antibodies against severe acute respiratory syndrome coronavirus. Clin Diagn Lab Immunol (2005) 0.84
RNA polymerase I-driven reverse genetics system for enterovirus 71 and its implications for vaccine production. Virol J (2012) 0.83
Oral vaccination of baculovirus-expressed VP28 displays enhanced protection against White Spot Syndrome Virus in Penaeus monodon. PLoS One (2011) 0.83
Monoclonal Antibody Targeting Neutralizing Epitope on H5N1 Influenza Virus of Clade 1 and 0 for Specific H5 Quantification. Influenza Res Treat (2013) 0.82
Avian encephalomyelitis virus nonstructural protein 2C induces apoptosis by activating cytochrome c/caspase-9 pathway. Virology (2004) 0.82
Induction of protective immune responses against EV71 in mice by baculovirus encoding a novel expression cassette for capsid protein VP1. Antiviral Res (2012) 0.82
Intranasal immunization of baculovirus displayed hemagglutinin confers complete protection against mouse adapted highly pathogenic H7N7 reassortant influenza virus. PLoS One (2013) 0.81
Three-dimensional orientation of iris in an ocular prosthesis using a customized scale. J Prosthodont (2013) 0.81
Porcine circovirus type 2 ORF3 protein competes with p53 in binding to Pirh2 and mediates the deregulation of p53 homeostasis. Virology (2009) 0.81
Avian encephalomyelitis virus induces apoptosis via major structural protein VP3. Virology (2002) 0.81
Identification of novel attenuated Salmonella Enteritidis mutants. FEMS Immunol Med Microbiol (2008) 0.81
Reverse micelle-encapsulated recombinant baculovirus as an oral vaccine against H5N1 infection in mice. Antiviral Res (2010) 0.80
Immune responses to baculovirus-displayed enterovirus 71 VP1 antigen. Expert Rev Vaccines (2013) 0.80
Deletion of the aceE gene (encoding a component of pyruvate dehydrogenase) attenuates Salmonella enterica serovar Enteritidis. FEMS Immunol Med Microbiol (2011) 0.80
Development of a sensitive and specific epitope-blocking ELISA for universal detection of antibodies to human enterovirus 71 strains. PLoS One (2013) 0.79
Enhanced replication of porcine circovirus type 2 (PCV2) in a homogeneous subpopulation of PK15 cell line. Virology (2007) 0.79
Development of an ELISA using a recombinant 41 kDa partial protein (P45N') for the detection of Riemerella anatipestifer infections in ducks. Vet Microbiol (2002) 0.79
Evaluation of a Subunit H5 Vaccine and an Inactivated H5N2 Avian Influenza Marker Vaccine in Ducks Challenged with Vietnamese H5N1 Highly Pathogenic Avian Influenza Virus. Influenza Res Treat (2010) 0.79
Inhibition of porcine circovirus type 2 replication in mice by RNA interference. Virology (2006) 0.79
A novel baculovirus vector shows efficient gene delivery of modified porcine reproductive and respiratory syndrome virus antigens and elicits specific immune response. Vaccine (2013) 0.79
Membrane-association properties of avian encephalomyelitis virus protein 3A. Virology (2004) 0.78
Sf-PHB2, a new transcription factor, drives WSSV Ie1 gene expression via a 12-bp DNA element. Virol J (2012) 0.78
The VP1 protein of avian encephalomyelitis virus is a major host-protective immunogen that serves as diagnostic potential. J Virol Methods (2008) 0.78
Display of enterovirus 71 VP1 on baculovirus as a type II transmembrane protein elicits protective B and T cell responses in immunized mice. Virus Res (2012) 0.78
Characterization of a novel monoclonal antibody reactive against the N-terminal region of Enterovirus 71 VP1 capsid protein. J Virol Methods (2012) 0.78
Development of dual-function ELISA for effective antigen and antibody detection against H7 avian influenza virus. BMC Microbiol (2013) 0.78
Suppression of porcine arterivirus replication by baculovirus-delivered shRNA targeting nucleoprotein. Biochem Biophys Res Commun (2006) 0.77
Identification and characterization of a monoclonal antibody recognizing the linear epitope RVADVI on VP1 protein of enterovirus 71. J Med Virol (2012) 0.77
Production of a monoclonal antibody specific for the major outer membrane protein of Campylobacter jejuni and characterization of the epitope. Appl Environ Microbiol (2007) 0.77
Subcutaneous immunization with baculovirus surface-displayed hemagglutinin of pandemic H1N1 Influenza A virus induces protective immunity in mice. Clin Vaccine Immunol (2011) 0.77
Characterization and epitope mapping of monoclonal antibodies recognizing N-terminus of Rep of porcine circovirus type 2. J Virol Methods (2010) 0.76
Recombinant baculovirus associated with bilosomes as an oral vaccine candidate against HEV71 infection in mice. PLoS One (2013) 0.76